Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

Physicians' Education Resource - Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective

Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective

Date

21 Nov 2020

Session

Physicians' Education Resource - Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective

Topics

Targeted Therapy

Tumour Site

Presenters

Maurice Pérol

Authors

M. Toi1, J. Tabernero2, M. Pérol3

Author affiliations

  • 1 Breast Unit, Kyoto University-Graduate school of medicine, 606-8507 - Kyoto/JP
  • 2 Medical Oncology Dept., Vall d'Hebron University Hospital, 8035 - Barcelona/ES
  • 3 Medical Oncology Dept, Centre Léon Bérard, 69008 - Lyon/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Post session Survey and Q&A Session

Presenter: Masakazu Toi

Session: Physicians' Education Resource - Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.